‘Friendly Breakup’: Sanofi And Regeneron Agree Equity Revamp
Pair Say Stock Move Will Not Hurt Their Drug Development Pact
Sanofi to sell most of its Regeneron stake, with much of it being re-purchased by Regeneron, but both stressed the move would not hurt their long established and very profitable drug-development collaboration.
